[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condbio:medulloblastoma:histone-h3-lysine-28":3},{"condition":4,"biomarker":5,"total":6,"trials":7},"Medulloblastoma","Histone H3 Lysine 28",3,[8,16,23],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT06639607","PEP-CMV + Nivolumab for Newly Diagnosed Diffuse Midline Glioma\u002FHigh-grade Glioma and Recurrent Diffuse Midline Glioma\u002FHigh-grade Glioma, Medulloblastoma, and Ependymoma",[12],"Phase 1\u002FPhase 2","RECRUITING","2026-08-03T00:58:26.564367Z","2026-07-05T05:32:16.689130Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":21,"content_modified":22},"NCT04099797","C7R-GD2.CAR T Cells for Patients With GD2-expressing Brain Tumors (GAIL-B)",[20],"Phase 1","2026-08-26T02:16:22.235886Z","2026-05-05T02:43:27.089113Z",{"nct_id":24,"title":25,"phases":26,"status":27,"updated_at":28,"content_modified":29},"NCT05835687","Loc3CAR: Locoregional Delivery of B7-H3-CAR T Cells for Pediatric Patients With Primary CNS Tumors",[20],"ACTIVE_NOT_RECRUITING","2026-08-03T03:23:28.660374Z","2026-05-05T02:43:27.753658Z"]